During this discussion, we talked to Lynn Barr, CEO and founder of Caravan Health, and she shared insights into the Medicare Shared Savings “Pathways to Success" Program.

Jordan Bazinsky, executive vice president and administrative officer for Cotiviti, breaks down various factors impacting innovation, including market trends that he believes are both headwinds and tailwinds to innovation, as well as shares a framework based on what’s happening in the current health…

Steven Feldman, MD, PhD, professor of dermatology at the Wake Forest School of Medicine, discusses costs associated with psoriasis drugs and focuses specifically on the impact these costs have on insurers.

Nan Li, health outcomes researcher at Janssen, discusses the importance of understanding health care utilization, expenditures, and work productivity among patients with RA with or without comorbidities.

By Julie Gould Podcast Series:  In this episode, Steven Albelda, MD, professor of medicine at the University of Pennsylvania, Pulmonary Division, discusses a $10 million grant that Penn Medicine recently received from the National Cancer Institute and explains how a team of…

By Julie Gould Podcast Series: In this episode, Elizabeth Budde, MD, PhD, assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope, discusses recommendations that were recently created by a National Comprehensive Cancer Network task force for…

By Zachary Bessette Podcast Series: Gary Goldstein, business manager of the Blood and Marrow Transplant Program at Stanford Health Care, discusses the changes needed for increased CAR-T administration in the outpatient setting as well as commercial and provider concerns about the latest…

By Zachary Bessette Podcast Series: Michael R. Bishop, MD, Director, Cellular Therapy Program, University of Chicago Medicine, discusses the challenges providers face when navigating Medicare and Medicaid policy for administering chimeric antigen receptor (CAR) T-cell therapy as well as…

By David Costill Podcast Series: We discuss the clinical aspects and mechanism of CAR-T therapy for the treatment of hematological malignancies with Nicole Trask, PharmD, a clinical consultant Pharmacist at UMass Medical School.  

By Dave Costill In this episode of the First Report Managed Care podcast, we spoke with Russell J Spjut, PharmD, about how the emergence of FDA-Approved CAR-T therapies for the treatment of hematological malignancies could impact managed care.